CellBion Co., Ltd.
CellBion Co., Ltd., headquartered in South Korea (KR), is a prominent player in the biotechnology industry, specialising in innovative cell therapy solutions. Founded in 2015, the company has rapidly established itself as a leader in regenerative medicine, focusing on the development and commercialisation of advanced cellular products. With a strong operational presence in Asia and beyond, CellBion offers unique services in cell culture and manipulation, catering to both research and clinical applications. Their flagship products, which include cutting-edge stem cell lines and customised cell solutions, are distinguished by their high purity and efficacy, setting new standards in the field. Recognised for its commitment to quality and innovation, CellBion has achieved significant milestones, positioning itself as a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does CellBion Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CellBion Co., Ltd.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CellBion Co., Ltd.'s reported carbon emissions
In 2024, CellBion Co., Ltd. reported total carbon emissions of approximately 304,343,000 kg CO2e for Scope 1 and 50,705,000 kg CO2e for Scope 2. This reflects a slight decrease from 2023, where emissions were about 313,807,000 kg CO2e for Scope 1 and 35,821,000 kg CO2e for Scope 2. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not reported any Scope 3 emissions. CellBion has not set specific reduction targets or initiatives as part of its climate commitments, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi). The company’s emissions intensity for Scope 1 and 2 combined is reported at approximately 1,380 kg CO2e per tonne of output for 2024. As of now, there are no cascaded emissions data from a parent or related organisation, indicating that all reported figures are directly from CellBion Co., Ltd. The company continues to monitor its carbon footprint as part of its operational strategy in South Korea.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 313,807,000 | 000,000,000 |
| Scope 2 | 35,821,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CellBion Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
